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The delta neutrophil index predicts 
development of multiple organ 
dysfunction syndrome and 30-
day mortality in trauma patients 
admitted to an intensive care unit: 
a retrospective analysis
Taeyoung Kong1,2, Yoo Seok Park1, Hye Sun Lee  3, Sinae Kim3, Jong Wook Lee4, Je Sung You  1, 
Hyun Soo Chung1, Incheol Park1 & Sung Phil Chung1
No studies have examined the role of delta neutrophil index (DNI) reflecting on immature granulocytes 
in determining the severity of multiple organ dysfunction (MODS) and short-term mortality. This study 
investigated the utility of the automatically calculated DNI as a prognostic marker of severity in trauma 
patients who were admitted to an intensive care unit (ICU). We retrospectively analysed prospective 
data of eligible patients. We investigated 366 patients. On multivariable logistic regression analysis, 
higher DNI values at 12 h (odds ratio [OR], 1.079; 95% confidence interval [CI]: 1.037–1.123; p < 0.001) 
and 24 h were strong independent predictors of MODS development. Multivariable Cox regression 
analysis revealed that increased DNI at 12 h (hazard ratio [HR], 1.051; 95% CI, 1.024–1.079; p < 0.001) 
was a strong independent predictor of short-term mortality. The increased predictability of MODS after 
trauma was closely associated with a DNI > 3.25% at 12 h (OR, 12.7; 95% CI: 6.12–26.35; p < 0.001). 
A cut-off of >5.3% at 12 h was significantly associated with an increased risk of 30-day mortality (HR, 
18.111; 95% CI, 6.988–46.935; p < 0.001). The DNI is suitable for rapid and simple estimation of the 
severity of traumatic injury using an automated haematologic analyser without additional cost or time.
Despite recent therapeutic advances, the World Health Organization assesses that injury causes 5.8 million death 
annually, and that this number is increasing worldwide1,2. Trauma-related mortality and disability is a major 
public health issue2,3. Moreover, the distribution of the timing of traumatic deaths is tri-modal3: traumas owing to 
non-salvageable injuries result in immediate deaths4; haemorrhagic or neurologic conditions, including haemor-
rhagic injuries of abdominal organs or expanding intracranial mass lesions, cause early death within the first 24 h 
following severe trauma4,5; and complications such as disseminated intravascular coagulopathy, sepsis, acute res-
piratory distress syndrome, and multiple organ dysfunction syndrome (MODS) cause late deaths days or weeks 
after injury in many trauma victims4,5. A strong immune response to traumatic injury is considered a critical 
factor in eliciting life-threatening conditions5. MODS remains the primary cause of late death after severe trauma, 
including up to 30% of deaths that are deemed possibly preventable6,7. Patents with MODS experience increased 
lengths of stay in intensive care units (ICUs) and may require renal replacement therapy6,7. Therefore, clinical 
improvement and survival in patients with major traumatic injuries require early recognition of their conditions 
and interventions to prevent the development of MODS6,7.
1Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. 2Department 
of Emergency Medicine, Graduate School of Medicine, Kangwon National University, Chuncheon, Republic of Korea. 
3Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, 
Republic of Korea. 4Department of Laboratory Medicine, Konyang University Hospital, Daejeon, Republic of Korea. 
Correspondence and requests for materials should be addressed to J.S.Y. (email: youjsmd@yuhs.ac)
Received: 3 April 2018
Accepted: 9 November 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCiENtifiC REPORTs |         (2018) 8:17515  | DOI:10.1038/s41598-018-35796-4
Technological advances in automated haematological analysers have enabled the acquisition of the delta neu-
trophil index (DNI) using leukocyte differentials obtained from two independent channels, the myeloperoxidase 
tungsten-halogen channel and the lobularity/nuclear density channel8,9. The DNI reflects the proportion of circu-
lating immature granulocytes and is calculated as the difference between the leukocyte differentials measured in 
the myeloperoxidase channel and the differentials detected in the lobularity channel8,9. A previous study showed 
that the DNI (as calculated using an automated blood cell analyser) was strongly correlated with the manual 
immature granulocyte counts (r = 0.75, p < 0.05)10; an increase in the number of immature granulocytes in circu-
lation is an important criterion in the diagnosis of systemic inflammatory response syndrome11. Several studies 
have found that a higher DNI value is closely associated with a positive blood culture, septic shock, disseminated 
intravascular coagulation, and mortality in critical care patients with suspected sepsis10–13. Recently, an increased 
DNI was also shown to reflect the severity of sterile inflammation-linked diseases such as out-of-hospital cardiac 
arrest, upper gastrointestinal haemorrhage, pulmonary embolism, and acute myocardial infarction8,14,15.
In patients with traumatic injury, systemic inflammatory response syndrome is abruptly initiated within 
30 minutes of major traumatic injury, and is an inflammatory response to hypoperfusion and reperfusion owing 
to blood loss and tissue damage rather than infection2. As a result, the systemic response to severe injury leads to 
multiorgan failure (MOF) and sepsis that compounds the original traumatic injury2. Tissue injury after trauma 
releases damage-associated molecular patterns from necrotic cells, which activate immune cells such as neutro-
phils2. Increased pro-inflammatory cytokines activate neutrophils that elicit the destruction of healthy organ 
tissues with proteases and reactive oxygen species, and also sequestrate neutrophils in bystander organs by 
migrating across damaged endothelium2. Major loss of blood components, including neutrophils, occurs fol-
lowing an injury owing to vascular damage and massive haemorrhage16,17. To compensate for the tremendous 
depletion and demand for activated neutrophils following their marked loss owing to consumption, sequestra-
tion, and destruction of mature cells, the switch to emergency granulopoiesis considerably enhances the release 
of immature granulocytes by rapid production and turnover of cells into the peripheral blood from the bone 
marrow16–19. As a consequence of severe inflammation, the dysregulated neutrophil function, known as neutro-
phil paralysis, further impairs the migration of neutrophils, and causes unwanted antimicrobial responses and 
neutrophil sequestration in remote organs20. In patients with severe traumatic injuries such as haemorrhage and 
damage to organs and tissues, the release of immature granulocytes into circulation may contribute to the failure 
to protect against infection and the risk of MOF21,22.
To the best of our knowledge, no study has assessed the ability of serial DNI measurements to predict the 
clinical severities of MODS and short-term mortality, nor have any DNI cut-off values that predict the severity of 
trauma patients admitted to an ICU been derived. Hence, in this study, we investigated the clinical utility of the 
DNI as a predictor of severity in trauma patients admitted to an ICU.
Results
Study population and clinical evaluation. Figure 1 shows the enrolment and clinical outcomes of 
trauma patients admitted to the ICU. 366 patients (mean age 50.5 ± 18.8 years) with a mean ISS of 28.7 ± 11.5 
were enrolled. Thirty-seven patients (10.1%) had died by day 30. The ISS was significantly greater in the non-sur-
vival group (41.5 ± 13.8) than in the survival group (27.3 ± 10.3; p < 0.001). Sixty patients (17.2%) developed 
MODS in the ICU (Table 1). The linear mixed model suggested that changes in DNI values from ED admission to 
48 h later were different between the groups over time; there were significant changes in DNI values as correlated 
with 30-day mortality and MODS (Fig. 2A,B).
DNI as predictor of 30-day mortality and MODS development. Univariate Cox and logistic regres-
sion analyses revealed that DNI values were significantly different at 12 h in patients who died within 30 days or 
experienced MODS versus those who did not (Supplement 1). The multivariable Cox regression model demon-
strated that an increased DNI value at 12 h after ED admission (HR, 1.051; 95% CI, 1.024–1.079; p < 0.001) 
was a strong independent predictor of short-term mortality among severe trauma patients admitted to an ICU 
(Table 2). On multivariable logistic regression analysis, higher DNI values at 12 and 24 h after ED admission were 
also strong independent predictors of the development of MODS (Table 3). The AUCs for predicting MODS using 
the DNI at 12 and 24 h among patients admitted to an ICU with severe trauma were 0.776 (p- < 0.001) and 0.762 
(p < 0.001), respectively (Fig. 2C,D).
Comparison of DNI and conventional clinical markers as predictors of 30-day mortality and 
MODS in critically ill trauma patients. To predict MODS development, ROC comparisons showed that 
the AUC of the DNI at 12 h was not significantly inferior to those of other markers (APACHE II, ISS, total trans-
fused packed red blood cell volumes, and lactate on ED admission, and 24 h) except for the SOFA. Moreover, 
the DNI value at 24 h was not significantly inferior to those of other markers, including SOFA, APACHE II, and 
lactate, at 24 h. However, it was significantly superior to lactate and ISS on ED admission (Supplement 2). Using 
Youden’s method, the optimal cut-offs for the DNI values at 12 and 24 h were found to be 3.25% (sensitivity: 83.1 
[71–91.6]; specificity: 72.2 [66.4–77.4]) and 2.85% (sensitivity: 75.4 [62.2–85.9]; specificity: 76.9 [71.5–81.8]), 
respectively. A DNI value > 3.25% was closely associated with the probability of MODS after trauma at 12 h after 
ED admission (OR, 12.7; 95% CI: 6.12–26.35; p < 0.001), as was a DNI value > 2.85% at 24 h (OR, 10.24; 95% CI: 
5.26–19.92; p < 0.001) (Fig. 2C,D). To estimate the optimal cut-off values based on time-to-event data, we created 
Kaplan-Meier curves for 30-day mortality according to DNI values (Fig. 3); a log-rank test at 12 h after ED admis-
sion showed that these DNI cut-off values were independent predictors of 30-day mortality (p < 0.001). Harrell’s 
C-index for the prediction of 30-day mortality using the DNI was 0.876 (95% CI 0.831–0.916, p < 0.001) at 12 h 
after ED admission (Fig. 4A). The optimal DNI cut-off value for predicting 30-day mortality, the identification 
of which was a primary aim of this study, was 5.3% at 12 h after ED admission (p < 0.001). On further analysis 
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using the Contal and O’Quigley technique, a DNI cut-off of >5.3% at 12 h after ED admission was significantly 
associated with an increased risk of 30-day mortality (HR, 18.11; 95% CI, 6.99–46.94; p < 0.001) among patients 
admitted to an ICU with severe trauma. Compared to the derived Harrell C-index, the C-statistic of the DNI 
at 12 h was not statistically inferior to those of other markers (i.e., it was similar to the SOFA, APACHE II, ISS, 
lactate at 24 h, and PT at 12 h). Conversely, the C-statistic of the DNI at 12 h was statistically superior to those of 
lactate, PT, and tCO2 on ED admission (Fig. 4B and Supplement 3).
The prognostic value of DNI when combined with conventional risk factors. The IDI and NRI 
are indicators of improvements following reclassification in a nested model, and can thus determine whether the 
predictive power of a combination of traditional factors is improved upon DNI inclusion. The addition of the 
Figure 1. Flow diagram of patient enrolment (A) and the criteria for trauma critical pathway activation (B).
www.nature.com/scientificreports/
4SCiENtifiC REPORTs |         (2018) 8:17515  | DOI:10.1038/s41598-018-35796-4
Variables
30-day Mortality Development of MODS
Total  
N = 366 (100%)
Survival  
N = 329 (89.9%)
Death  
N = 37 (10.1%) P
Total  
N = 348 (100%)
No  
N = 288 (82.8%)
Yes  
N = 60 (17.2%) P
Age (years) 50.536 ± 18.758 49.687 ± 18.548 58.081 ± 19.172 0.01* 50.046 ± 18.776 49.785 ± 18.685 51.300 ± 19.317 0.57
Male sex [n (%)] 264(72.13) 238(72.34) 26(70.27) 0.79 251(72.13) 204(70.83) 47(78.33) 0.239
BMI (kg/m2) 23.883 ± 3.532 23.833 ± 3.529 24.331 ± 3.573 0.417 23.893 ± 3.564 23.838 ± 3.529 24.159 ± 3.746 0.529
ISS (point) 28.697 ± 11.497 27.255 ± 10.275 41.514 ± 13.803 <0.001* 28.023 ± 11.062 26.201 ± 9.258 36.767 ± 14.452 <0.001*
APACHE II score (point) 11.59 ± 7.099 10.416 ± 5.943 22.027 ± 8.036 <0.001* 11.003 ± 6.621 9.809 ± 5.549 16.733 ± 8.227 <0.001*
SOFA score (point) 4.88 ± 3.947 4.161 ± 3.35 11.27 ± 3.006 <0.001* 4.486 ± 3.602 3.451 ± 2.749 9.450 ± 3.039 <0.001*
Initial vital sign
Mean blood pressure (mmHg) 82.165 ± 24.224 84.966 ± 21.476 57.261 ± 32.224 <0.001* 83.727 ± 22.819 85.770 ± 21.557 73.922 ± 26.153 0.002*
Heart rate (bpm) 92.336 ± 24.365 93.267 ± 20.879 84.054 ± 44.369 0.22 92.894 ± 23.278 92.219 ± 21.691 96.133 ± 29.752 0.337
Respiratory rate (bpm) 17.915 ± 4.178 18.085 ± 3.819 16.405 ± 6.444 0.128 17.615 ± 3.8 18.101 ± 3.556 17.167 ± 5.823 0.236
Body temperature (°C) 36.346 ± 0.64 36.372 ± 0.65 36.119 ± 0.5 0.022* 36.361 ± 0.646 36.431 ± 0.590 36.027 ± 0.788 <0.001*
Mental change [n (%)] 67(18.31) 47(14.29) 20(54.05) <0.001* 56(16.09) 31(10.76) 25(41.67) <0.001*
Mechanism [n (%)] 0.125 0.749
Motor vehicle accident at high 
speed 45(12.3) 42(12.77) 3(8.11) 44(12.64) 34(11.81) 10(16.67)
Ejection or rollover of vehicle 14(3.83) 13(3.95) 1(2.7) 13(3.74) 10(3.47) 3(5)
Pedestrian stuck by moving 
vehicle 111(30.33) 94(28.57) 17(45.95) 101(29.02) 83(28.82) 18(30)
Bicycle accident > 20 km 
impact 7(1.91) 5(1.52) 2(5.41) 7(2.01) 6(2.08) 1(1.67)
Fall > 3 m 86(23.5) 76(23.1) 10(27.03) 80(22.99) 65(22.57) 15(25)
Motorcycle accident 60(16.39) 58(17.63) 2(5.41) 60(17.24) 53(18.4) 7(11.67)
Crushing injury 19(5.19) 18(5.47) 1(2.7) 19(5.46) 15(5.21) 4(6.67)
Stab wound 24(6.56) 23(6.99) 1(2.7) 24(6.9) 22(7.64) 2(3.33)
Comorbidity [n (%)]
Hypertension 107(29.23) 94(28.57) 13(35.14) 0.405 91(26.15) 73(25.35) 18(30.00) 0.456
Diabetes mellitus 65(17.76) 56(17.02) 9(24.32) 0.27 53(15.23) 43(14.93) 10(16.67) 0.734
Chronic pulmonary disease 23(6.28) 21(6.38) 2(5.41) >0.999 21(6.03) 17(5.90) 4(6.67) 0.769
Cardiovascular disease 24(6.56) 21(6.38) 3(8.11) 0.723 23(6.61) 18(6.25) 5(8.33) 0.568
Old cerebrovascular accident 7(1.91) 7(2.13) 0(0.00) >0.999 7(2.01) 6(2.08) 1(1.67) 0.999
Malignancy 9(2.46) 8(2.43) 1(2.70) >0.999 8(2.30) 8(2.78) 0(0.00) 0.36
Chronic liver disease 5(1.37) 3(0.91) 2(5.41) 0.082 4(1.15) 2(0.69) 2(3.33) 0.139
Chronic kidney disease 7(1.91) 7(2.13) 0(0.00) >0.999 7(2.01) 6(2.08) 1(1.67) 0.999
Treatment within 24 hours [n (%)]
Surgery 135(36.89) 112(34.04) 23(62.16) <0.001* 122(35.06) 92(31.94) 30(50.00) 0.008*
Embolization 71(19.40) 59(17.93) 12(32.43) 0.035* 64(18.39) 47(16.32) 17(28.33) 0.029*
Conservative management 179(48.91) 170(51.67) 9(24.32) 0.002* 177(50.86) 156(54.17) 21(35.00) 0.007*
Transfusion in first 24 hours
Packed red blood cells (Unit) 4.156 ± 8.185 2.964 ± 6.525 14.757 ± 12.764 <0.001* 3.184 ± 6.584 1.917 ± 3.949 9.267 ± 11.561 <0.0001*
Fresh Frozen Plasma (Unit) 2.806 ± 6.561 1.875 ± 4.947 11.081 ± 11.625 <0.001* 2.043 ± 5.021 1.104 ± 3.356 6.550 ± 8.278 <0.0001*
Platelet concentrate (Unit) 2.593 ± 6.451 1.733 ± 5.327 10.243 ± 9.825 <0.001* 1.931 ± 5.445 0.819 ± 2.847 7.267 ± 9.998 <0.0001*
Laboratory data
White blood cell count (103/μL) 12.748 ± 5.073 12.884 ± 5.147 11.538 ± 4.235 0.126 12.864 ± 5.113 13.023 ± 5.164 12.104 ± 4.829 0.206
Hemoglobin (g/dL) 12.94 ± 2.344 13.056 ± 2.313 11.914 ± 2.4 0.005* 13.017 ± 2.34 13.069 ± 2.285 12.770 ± 2.598 0.369
Platelet count (103/μL) 231.86 ± 77.021 234.27 ± 75.407 210.43 ± 88.387 0.074 233.22 ± 77.358 236.649 ± 74.141 216.750 ± 90.126 0.114
PT (INR) 1.033 ± 0.235 1.012 ± 0.186 1.215 ± 0.454 0.011* 1.021 ± 0.203 1.005 ± 0.184 1.098 ± 0.266 0.012*
BUN (mg/dL) 16.896 ± 6.707 16.712 ± 6.629 18.541 ± 7.262 0.116 16.818 ± 6.571 16.889 ± 6.730 16.475 ± 5.786 0.658
Creatinine (mg/dL) 0.995 ± 0.734 0.967 ± 0.726 1.244 ± 0.77 0.029* 0.979 ± 0.712 0.944 ± 0.699 1.151 ± 0.755 0.040*
AST (IU/L) 136.64 ± 180.69 130.84 ± 168.15 188.19 ± 265.28 0.206 132.99 ± 166.17 122.372 ± 155.957 183.933 ± 202.231 0.029*
ALT (IU/L) 92.975 ± 143.21 89.134 ± 128.83 127.14 ± 235.35 0.34 90.397 ± 127.58 83.396 ± 120.905 124.000 ± 152.402 0.056
Lactate (mmol/L) 3.941 ± 3 3.562 ± 2.58 7.178 ± 4.209 <0.001* 3.811 ± 2.905 3.333 ± 2.445 6.140 ± 3.757 <0.001*
Potassium (mmol/L) 4.045 ± 0.572 4.034 ± 0.542 4.141 ± 0.793 0.431 4.043 ± 0.557 4.050 ± 0.519 4.012 ± 0.713 0.697
tCO2 (mmol/L) 18.858 ± 3.534 19.119 ± 3.332 16.541 ± 4.394 0.001* 18.92 ± 3.479 19.299 ± 3.245 17.100 ± 3.986 <0.001*
DNI Time-0 (%) 1.963 ± 4.305 2.055 ± 4.483 1.149 ± 2.011 0.031* 2.049 ± 4.396 2.053 ± 4.547 2.032 ± 3.616 0.969
DNI Time-12 (%) 4.953 ± 8.379 4.102 ± 7.951 13.027 ± 8.138 <0.001* 4.469 ± 8.026 3.234 ± 6.833 10.180 ± 10.407 <0.001*
DNI Time-24 (%) 4.539 ± 9.319 3.749 ± 8.121 15.782 ± 16.114 0.002* 4.414 ± 9.279 2.085 ± 4.517 15.568 ± 15.927 <0.001*
DNI Time-48 (%) 3.888 ± 10.305 2.94 ± 8.013 18.863 ± 23.615 0.009* 3.877 ± 10.319 1.353 ± 3.877 15.191 ± 19.094 <0.001*
Table 1. Clinical characteristics of patients stratified by 30-day mortality and development of multiple organ 
dysfunction syndrome. BMI, body mass index; ISS, injury severity score; APACHE II, Acute Physiology and 
Chronic Health Evaluation; SOFA, sequential organ failure assessment; PT, prothrombin time; BUN, blood urea 
nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; DNI, delta neutrophil index. *P < 0.05.
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DNI at 12 h after ED admission yielded a significantly positive IDI with respect to predicting 30-day mortality; 
the continuous NRI was also positive and was significant for the DNI at 12 h. Additionally, the diagnostic perfor-
mance was significantly improved by adding DNI to the reference model for predicting MODS according to the 
IDI and NRI (Table 4).
The effect of early significant intervention on the predictability of DNI values. Of the 366 
patients, 213 (58.2%) underwent at least one of the early significant interventions (transfusion, n = 173, emboli-
zation, n = 66, and surgery, n = 101) within 12 hours after ED admission. We compared the predictability of DNI 
values for the development of MODS and 30-day mortality between patients who underwent at least one of the 
early significant interventions within 12 hours after ED admission and patients who received conservative man-
agement. There was no significant difference of the predictability of DNI values for the development of MODS 
between intervention (0.806 (95% CI: 0.734–0.879)) and conservative (0.846 (95% CI: 0.732–0.960)) groups 
(p = 0.563)). There was also no significant difference for predictability of DNI values for the 30-day mortality 
between the intervention (0.841 (95% CI: 0.784–0.884)) group and the conservative (0.917(95% CI: 0.883–0.98)) 
group (p = 0.157). Consequently, the predictability of DNI values in patients who underwent early significant 
intervention was similar to the total enrolled patient population and patients who received conservative manage-
ment (Supplements 4 and 5).
Discussion
We demonstrated that an increased DNI value, which reflects the fraction of immature granulocytes, was a sig-
nificant independent predictor of the development of MODS and 30-day mortality. Despite advances in scoring 
systems and laboratory markers, the early recognition of severe complications such as the development of MODS 
and risk stratification for late death in traumatic injury remains challenging. The SOFA was originally developed 
Figure 2. Linear mixed model of the delta neutrophil index (DNI) to estimate significant differences between 
groups over time according to 30-day mortality (A) and development of multiple organ dysfunction syndrome 
(MODS) (B). The receiver operating characteristic curves for predictability of the DNI at 12 h (C) and 24 h (D) 
after admission according to MODS development.
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as a descriptive score23; its final score is based on the degree of dysfunction of six organ systems as measured 
via several physiologic and laboratory results23. Although the SOFA is used to determine multiple organ failure 
(MOF) in trauma, it does not propose a cut-off value for MOF development23. The APACHE II score estimates 
mortality in the ICU based on a number of laboratory values and indicators of both acute and chronic diseases24. 
The ISS as an anatomical scoring system that provides an overall score for patients with multiple injuries and 
correlates linearly with mortality24. However, it is often difficult to fully determine the extent of injury before 
thorough investigation (and if required, surgery).
Neither the SOFA nor APACHE II scoring system predicts MODS after injury24. Durham et al. demonstrated 
that MOF was associated only with APACHE III; total blood products transfused in the first 24 h, and lactate 
levels at 24 h25. Our data showed that the AUCs of the DNI at 12 and 24 h were not statistically inferior to those 
of the APACHE II, total transfused packed red blood cell volumes, or lactate level at 24 h. Considering the efforts 
required to predict severity, including serial measurements over time, these scoring systems are excessively com-
plicated for patients with trauma26.
As a screening tool for severely traumatized patients, we found that the DNI at 12 h after ED admission 
could predict the development of MODS and short-term mortality earlier than several other scoring systems. 
Inflammatory cytokines and C-reactive protein are also able to predict the development of organ failure with 
a high level of accuracy in traumatized patients27; even before clear clinical symptoms develop, interleukin-6 
(IL-6) kinetics in the first days of hospitalization may predict the development of MOF27. However, it is difficult 
to estimate the development of MOF using levels of C-reactive protein (that is increased in response to (IL-6 
secretion) 24 h after admission27. Although several pro-inflammatory cytokines like IL-6 can be usefully applied 
in clinical situations, additional costs, time, and new equipment must be considered for single or repeated meas-
urements to predict the severity of the patients’ conditions. Recent studies have explored the DNI as an adjunct 
predictor because inflammatory markers that can be measured rapidly, easily, serially, and inexpensively are an 
unmet need9,26. The automatically calculated DNI is a more prompt and accurate method than manually counting 
immature granulocytes10,14. Several studies have shown that an increased DNI is associated with poor outcomes 
in specific disease conditions and can predict the severity of infection and sterile inflammation9–11,14,15. Although 
the pathophysiologic mechanisms by which DNI values are associated with severity of disease are not fully under-
stood, several studies have elucidated the mechanisms by which immature granulocytes are released early and 
rapidly during severe inflammation9,15,26.
In the present study, we found that DNI values of >3.25% and >5.3% at 12 h post-admission were significant 
predictors of the development of MODS and 30-day mortality, respectively, in our trauma patients. Park et al. 
reported that severe sepsis and septic shock were significantly increased in patients with DNI > 6.5% in the first 
24 h after ICU admission11. Yune et al. also demonstrated that a DNI > 10.5% on day 1 was associated with a 
higher 30-day mortality rate after surviving out-of-hospital cardiac arrest14. Taken together, the data show that 
the DNI value reflects the severity of diseases associated with systemic and sterile inflammation. The use of the 
DNI, which can be measured rapidly, easily, and inexpensively, can be used to assess the severity of several dis-
eases because of the benefit of being automatically analysed as part of the complete blood count. Moreover, the 
present study revealed that the DNI value at 12 h post-ED admission predicted 30-day mortality with a reliability 
similar to those of the SOFA, APACHE II, ISS score, and lactate level at 24 h. Additionally, the DNI value 24 h 
post-admission was not inferior to the other factors (except for the SOFA) in predicting 30-day mortality. The 
DNI reflects the severity that is associated with MODS and short-term mortality, and produces predictive values 
that are statistically similar to several other scoring systems. Therefore, we cautiously propose that DNI values 
can be an ancillary test for the early prediction of injury/disease severity 12 h before other scoring systems such as 
the ISS, SOFA, and APACHE II, and is a serially measurable marker for monitoring severity over time in patients 
with trauma.
Variable
Multivariable cox proportional hazard regression analysis (30-day mortality)
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
ISS (per 1point) 1.026 (1.002–1.050) 0.032* 1.037 (1.012–1.062) 0.004* 1.024 (0.991–1.057) 0.154 1.031 (0.997–1.067) 0.075
APACHE II score (per 1point) 1.135 (1.072–1.201) <0.001* 1.108 (1.042–1.178) 0.001* 1.128 (1.048–1.215) 0.001* 1.090 (1.004–1.184) 0.039*
Transfusion of pRBC (per 1unit) 1.012 (0.986–1.039) 0.375 1.019 (0.991–1.048) 0.181 0.990 (0.948–1.033) 0.629 0.978 (0.922–1.036) 0.446
Treatment within 24 hours
Surgery 6.491 (1.611–26.158) 0.009* 4.009 (0.931–17.267) 0.062 5.150 (0.709–37.397) 0.105 4.556 (0.373–55.669) 0.235
Embolization 1.963 (0.777–4.958) 0.154 2.078 (0.792–5.450) 0.137 2.172 (0.523–9.026) 0.286 1.441 (0.257–8.092) 0.678
Conservative management 2.105 (0.444–9.982) 0.349 2.389 (0.444–12.865) 0.311 2.203 (0.265–18.314) 0.465 2.966 (0.210–41.858) 0.421
Prothrombin time (per 1 INR) 1.302 (0.528–3.206) 0.567 1.569 (0.575–4.281) 0.380 1.449 (0.364–5.763) 0.598 1.368 (0.252–7.414) 0.717
Lactate (per 1 mmol/L) 1.005 (0.903–1.118) 0.931 1.020 (0.910–1.144) 0.731 0.999 (0.872–1.145) 0.992 1.052 (0.907–1.219) 0.506
DNI Time-0 (per 1%) 0.867 (0.730–1.028) 0.101
DNI Time-12 (per 1%) 1.051 (1.024–1.079) <0.001*
DNI Time-24 (per 1%) 1.020 (0.987–1.055) 0.231
DNI Time-48 (per 1%) 1.043 (1.014–1.072) 0.003*
Table 2. Multivariable Cox proportional hazards regression analysis for predictors of 30-day mortality. ISS, 
injury severity score; APACHE II, Acute Physiology and Chronic Health Evaluation; pRBC, packed red blood 
cells; DNI, delta neutrophil index; *P < 0.05.
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This study had several limitations. First, despite using the prospective TRAUMA CP registry that had a stand-
ardized and predetermined protocol at our institution, our data from a single, tertiary, academic hospital were 
analysed retrospectively. We could not mandatorily and serially measure certain classification systems such as 
the Trauma and Injury Severity Score (TRISS), New Injury Severity Score, and APACHE III, nor could we inves-
tigate other inflammatory mediators such as tissue necrosis factor and other pro-inflammatory cytokines that 
are known indicators of trauma severity in our TRAUMA CP protocol28. Therefore, it was difficult to control for 
confounding factors, which increased the possibility of selection bias. However, we did investigate the TRISS 
(ISS plus the revised trauma score including systolic blood pressure, respiratory rate, and Glasgow Coma Scale) 
at limited time points. We also constructed a multivariable regression model considering the risk of multicollin-
earity and the possibility of overestimation or underestimation. We used the ISS, SOFA, and APACHE II scores 
as factors in this model because these scoring systems inherently introduced variability by not being applied 
consistently in our trauma patients. Sudarsanam et al. demonstrated that the APACHE II and APACHE III scores 
were strongly associated, with a correlation score of 0.829. In future studies, to validate the prognostic potential of 
DNI, a prospective study is needed to compare the predictive power of DNI values and other reliable indicators 
of organ dysfunction (such as APACHEIII, New Injury Severity Score, and cytokines) as an independent risk 
factor to add to reference prediction models. A second limitation was that we excluded patients admitted to the 
NCU to achieve homogeneity; hence, patients with severe brain injury may not have been included in this study. 
However, severe injury isolated to the brain is closely associated with higher mortality. Third, in an evaluation of 
the usefulness of a new marker when the marker is added to reference models with sufficient predictive power or 
standard risk factors, the application of AUC may be too conservative and the NRI and IDI may be overestimated. 
The statistical interpretation needs to be carefully considered due to the limitations of the two statistical methods.
Figure 3. The delta neutrophil index (DNI) as a predictor of 30-day mortality. Higher DNI values at 12 h (A) 
and 24 h (B) after admission were significantly associated with an increased risk of 30-day mortality among 
trauma patients admitted to an ICU.
Variable
Multivariable logistic regression analysis (Development of MODS)
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
ISS (per 1point) 1.047 (1.012–1.082) 0.008* 1.061 (1.023–1.101) 0.002* 1.045 (1.005–1.085) 0.026* 1.044 (1.006–1.084) 0.023*
APACHE II score (per 1point) 1.082 (1.017–1.151) 0.012* 1.065 (0.999–1.136) 0.055 1.058 (0.989–1.132) 0.101 1.062 (0.994–1.136) 0.075
Transfusion of pRBC (per 1unit) 1.102 (1.026–1.183) 0.008* 1.109 (1.029–1.196) 0.007* 1.089 (1.005–1.180) 0.038* 1.088 (1.009–1.174) 0.029*
Treatment within 24 hours
Surgery 4.423 (0.919–21.280) 0.064 2.215 (0.421–11.650) 0.348 2.346 (0.349–15.775) 0.381 2.476 (0.361–16.992) 0.356
Embolization 3.472 (0.835–14.435) 0.087 2.920 (0.650–13.116) 0.162 2.384 (0.414–13.739) 0.331 2.536 (0.424–15.163) 0.308
Conservative management 3.644 (0.612–21.700) 0.156 3.847 (0.595–24.861) 0.157 3.545 (0.423–29.711) 0.243 3.109 (0.365–26.500) 0.299
AST (per 1 IU/L) 1.001 (0.999–1.003) 0.482 1.001 (0.999–1.003) 0.462 1.001 (0.998–1.003) 0.622 1.000 (0.998–1.003) 0.70
Prothrombin time (per 1 INR) 1.189 (0.290–4.880) 0.810 1.424 (0.328–6.189) 0.637 0.918 (0.174–4.847) 0.920 1.457 (0.304–6.977) 0.638
Lactate (per 1 mmol/L) 1.091 (0.959–1.242) 0.187 1.085 (0.947–1.242) 0.240 1.072 (0.930–1.235) 0.338 1.068 (0.927–1.231) 0.364
DNI Time-0 (per 1%) 0.996 (0.914–1.086) 0.934
DNI Time-12 (per 1%) 1.079 (1.037–1.123) <0.001*
DNI Time-24 (per 1%) 1.125 (1.070–1.183) <0.001*
DNI Time-48 (per 1%) 1.121 (1.054–1.194) <0.001*
Table 3. Multivariable logistic regression analysis for predictors of the development of multiple organ 
dysfunction syndrome. ISS, injury severity score; APACHE II, Acute Physiology and Chronic Health 
Evaluation; pRBC, packed red blood cells; AST, aspartate aminotransferase; DNI, delta neutrophil index; 
*P < 0.05.
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Finally, our study did not clarify the precise mechanisms by which the DNI is associated with severity after 
traumatic injury. Large, prospective, randomized clinical trials, as well as additional targeted investigations, are 
required to address each of these limitations.
In conclusion, an increased DNI value is an independent predictor of MODS development and 30-day mor-
tality in trauma patients admitted to an ICU. The DNI is routinely and easily measurable as part of the complete 
blood count without additional cost or time, and can therefore be considered a suitable parameter for the early 
estimation of the severity of a traumatic injury.
Methods
Study population and the TRAUMA critical pathway (CP). A retrospective cohort single-centre study 
was performed in the emergency department (ED) of an urban, university-affiliated, tertiary referral medical centre 
with an annual census of approximately 85,000 visits. The study was approved by the institutional review board 
(No. 3-2017-0188) of Yonsei University Health System, which waived the requirement for written informed consent 
because of the retrospective nature of the study. All methods were performed in accordance with the relevant guide-
lines and regulations. This study enrolled eligible adult patients who were admitted to the ICU after enrolment in 
the TRAUMA CP of the ED between January 1, 2011, and May 31, 2017. Figure 1 shows the enrolment, TRAUMA 
CP alerting criteria, and clinical outcome data of patients suspected of having sustained severe trauma. To validate 
the usefulness of serial DNI measurements over time, we excluded patients who transferred from another hospital 
before admission to our institution’s ED, those who transferred out to another hospital within the first 96 h, those 
discharged against medical advice, and those who died in the ED. Additional exclusion criteria were a history of 
haematological malignancy or autoimmune disease, admission to the independent neurosurgical care unit (NCU) 
for isolated head injuries, and current pregnancy; moreover, those who died within the first 96 h after injury were not 
included in MODS-related analyses based on predetermined guidelines1,23. Considering the differences in intensive 
management, we excluded trauma patients treated in the NCU to maintain the homogeneity of the study cohort.
Our institution schedules specialized traumatologists and interventional radiologists to be on call 24 h/day, 
7 days/week, to treat patients who arrive at the ED requiring emergency surgical and radiological interventions. 
In 2011, our TRAUMA CP was designed and implemented for the effective management of adult patients (≥18 
years) suspected of having sustained severe trauma to reduce unnecessary in-hospital time delays through a com-
puterized provider order entry-based alert system, short message service, and simple standing orders through the 
activation stage28. TRAUMA CP records were prospectively obtained based on a predetermined protocol. In the 
triage area of the ED, physicians, nurses, or emergency medical technicians screened candidates for the TRAUMA 
CP program as soon as feasible using the Advanced Trauma Life Support (ATLS) guidelines28. When a patient 
had at least one of seven warning mechanisms and one of 10 clinical suspicions of severe trauma (known as the 
TRAUMA CP alerting criteria) on ED admission, an ED physician in the triage area activated the TRAUMA 
program by selecting the activation icon on the order-entry window (Fig. 1). The computerized provider order 
entry system highlights the name of the patient in purple and simultaneously submits medical orders according to 
a predetermined program. According to the predetermined protocol based on the ATLS guidelines, the trauma-
tologists and emergency physicians immediately evaluate the patient and simultaneously administer treatment28. 
Even if the system was activated, we excluded patients with minor injuries from our program to preserve the 
Figure 4. Comparison of Harrell’s C-index for the delta neutrophil index (DNI) for the prediction of 30-
day mortality according to time (A); and comparison of the area under the curve (AUC) for the DNI when 
predicting the development of multiple organ dysfunction syndrome (MODS) according to time (B). The 
Harrell’s C-index and AUC showed discriminative abilities for the risk stratification of 30-day mortality and 
development of MODS (statistical information is shown in supplements 2 and 3). (A) *Harrell’s C-index of DNI 
at 12 h was statistically superior to lactate, prothrombin time, and tCO2 on emergency department admission 
(p < 0.05). (B) *AUC of DNI at 12 h was statistically superior to lactate on emergency department admission 
and Injury Severity Score (p < 0.05). ¶AUC of DNI at 12 h was statistically inferior to the Sequential Organ 
Failure Assessment score at 24 h after emergency department admission (p < 0.05).
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cost-effective use of medical resources and limit radiation hazards. In the emergency setting, medical staff reas-
sessed each patient by performing a physical examination and ‘focused assessment with sonography for trauma’, 
and decided whether to include the patient in this program28. This protocol was applied for 24 h/7 days, where-
upon severe trauma patients received standard management from the ED to the ICU.
Data collection. We collected baseline characteristics including sex, age, previous medical history, mechanism 
of injury, mental status on arrival, vital signs, laboratory values, Injury Severity Score (ISS), and follow-up data 
for all patients based on a predetermined protocol. We also investigated whether packed red blood cells, fresh 
frozen plasma, and platelets were transfused in the first 24 h, and noted the main types of emergency treatment 
performed within 24 h of ED admission (including emergency surgery, angioembolization, and conservative 
care). The Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation 
(APACHE) II were obtained from the TRAUMA CP records to determine the clinical severity of each patient’s 
condition. Additional data were extracted from electronic sources on radiology, ICU progress notes, nursing 
charts, and discharge summaries.
The DNI values were obtained for all patients within 10 minutes of ED admission as well as 12 ± 3 h, 24 ± 3 h, 
and 48 ± 6 h after admission. The DNI for each patient was determined using venous blood in ethylenediamine-
tetraacetic acid (EDTA)-containing vacutainers on presentation to the ED. To assess the DNI, we used the same 
type of haematology analyser (ADVIA 2120; Siemens, Forchheim, Germany) used for the analysis of the complete 
blood count. We also conducted other laboratory tests including measuring white blood cell counts and levels 
of blood urea nitrogen, creatinine, electrolytes, alanine transaminase, and lactate at the time of ED admission.
DNI measurement. The analysers used to determine DNI were optical systems based on a cytochemical myeloper-
oxidase tungsten-halogen channel (which measures and differentiates neutrophils, eosinophils, lymphocytes, mono-
cytes, and large unstained cells based on size and myeloperoxidase staining intensity), and a laser-diode channel (that 
calculates, classifies, and counts cell types based on lobularity/nuclear density and size). The DNI was then calculated 
by subtracting the fraction of mature polymorphonuclear neutrophils from the sum of the myeloperoxidase-reactive 
cells, thus deriving the circulating immature granulocytes as the leukocyte sub-fraction10,12,14.
Clinical endpoints. Our primary endpoint was the development of MODS during in-hospital admission, which 
was defined as a Sequential Organ Failure Assessment Score of 6 or more on two or more consecutive days at 
least 48 h after ED admission5. Additionally, the secondary endpoint was all-cause mortality within 30 days of ED 
admission after sustaining trauma.
Statistical analysis. Demographic and clinical data are presented as percentages or frequencies, medians 
(interquartile ranges), and means ± standard deviations, as appropriate. We compared categorical variables using 
the χ2 test or Fisher’s exact test and continuous variables using a two-sample t-test or the Mann–Whitney U-test. 
Prediction model
30-day mortality
Harrell’s C-index (95% CI) Difference of C-index (95% CI) P IDI (95% CI) P NRI (95% CI) P
(A)
Reference(Ref.) model 0.917 (0.880–0.952)
Ref. model + DNI Time-0 0.916 (0.875–0.956) −0.001 (−0.016–0.011) 0.868 0.015 (−0.003–0.053) 0.098 0.117 (−0.217–0.267) 0.374
Ref. model + DNI Time-12 0.923 (0.885–0.958) 0.006 (−0.010–0.022) 0.453 0.063 (0.011–0.116) 0.012* 0.631 (0.244–0.721) 0.01*
Ref. model + DNI Time-24 0.895 (0.841–0.950) −0.022 (−0.057–0.012) 0.196 0.028 (−0.010–0.110) 0.128 0.014 (−0.308–0.311) 0.907
Ref. model + DNI Time-48 0.892 (0.830–0.955) −0.025 (−0.072–0.023) 0.317 0.112 (0.006–0.226) 0.040* −0.022 (−0.269–0.517) 0.999
Prediction model
Multiple organ dysfunction syndrome
AUROC (95% CI) Difference of AUROC (95% CI) P IDI (95% CI) P NRI (95% CI) P
(B)
Reference(Ref.) model 0.858
Ref. model + DNI Time-0 0.859 0.001(−0.001–0.002) 0.475 0(−0.001–0.001) 0.886 0.004(−0.003–0.011) 0.317
Ref. model + DNI Time-12 0.889 0.031(−0.004–0.067) 0.086 0.048(0.012–0.085) 0.009* 0.207(0.108–0.307) <0.001*
Ref. model + DNI Time-24 0.910 0.052(0.005–0.100) 0.031* 0.162(0.089–0.234) <0.001* 0.262(0.133–0.390) <0.001*
Ref. model + DNI Time-48 0.911 0.053(0.014–0.092) 0.008* 0.133(0.061–0.206) <0.001* 0.283(0.142–0.344) <0.001*
Table 4. Comparison of the performance of the survival models (A) and multiple organ dysfunction syndrome 
(B) with and without the delta neutrophil index (DNI) by Harrell’s C-index, area under the curve operating 
characteristic (AUROC), integrated discrimination improvement (IDI), and continuous net reclassification 
improvement (NRI). Harrell’s C-index showed discriminative abilities for the risk stratification of 30-day 
mortality (statistical information in Supplementary Table 2). *P < 0.05. Reference model = ISS + Acute 
Physiology and Chronic Health Evaluation (APACHE) II score + amount of transfused packed red blood 
cells + treatment modality + prothrombin time + arterial lactate level. DNI, delta neutrophil index. *P < 0.05. 
Reference model = ISS score + APACHE II score + amount of transfused packed red blood cells + treatment 
modality + prothrombin time + arterial lactate level + serum aspartate transaminase level. DNI, delta 
neutrophil index. *P < 0.05.
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Using a linear mixed model and repeated measures covariance pattern with unstructured covariance within 
patients, we evaluated significant differences between groups over time. Two fixed effects represented the clinical 
effect (level: survival vs. death by day 30 and development vs. non-development of MODS) and time effect (time: 
DNI determined on admission and at 12 h, 24 h, and 48 h after ED admission). Differences in clinical effect over 
time were analysed by the formula “clinical effect × time”.
We also measured significant differences concerning the development of MODS. Univariate Cox proportional 
hazards regression and logistic regression analyses were used to evaluate relationships among demographic char-
acteristics and clinical data for all-cause mortality at 30 days and the development of MODS. Multivariable Cox 
proportional hazards regression that integrated the major covariates (variables with a p-value < 0.05) identified by 
our univariate Cox proportional hazards regression analysis was used to determine potential independent predictors 
of 30-day mortality by considering time-to-event data. Additionally, multivariable logistic regression analysis was 
performed to assess potential independent predictors of the development of MODS. The results of multivariable Cox 
proportional hazards regression analyses are expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). 
Those of multivariable logistic regression analysis are represented as odds ratios (ORs) and 95% CIs. We determined 
the area under the curve (AUC) to assess the ability of the DNI to predict the development of MODS using receiver 
operating characteristic (ROC) curves. We assessed the optimal cut-off for the DNI using Youden’s method for dis-
criminating the development of MODS in trauma patients admitted to an ICU. Next, ROC curves were constructed 
to assess the diagnostic performance of the DNI and other clinical parameters, and the AUCs were calculated and 
compared. We also performed net reclassification improvement (NRI) and integrated discrimination improvement 
(IDI) to analyse the degree to which the addition of DNI to the reference model improved its predictive ability30.
We constructed Kaplan-Meier survival curves using 30-day mortality data, and compared groups using the 
log-rank test. The optimal cut-off values for the dichotomization of the clinical outcome variable were estimated 
based on time-to-event data using the technique devised by Contal and O’Quigley14,31. The optimal cut-off point 
was selected by maximizing the HR. To investigate the additional predictive power of the DNI at each time point, 
Harrell’s C-index was assessed to examine the time-dependent discriminatory ability against SOFA, APACHE II, 
and ISS on ICU admission; lactate, total CO2 and prothrombin time on ED admission; and lactate and prothrom-
bin time 24 h after ED admission versus the ability of DNI to predict 30-day mortality32. To assess the 95% CI and 
p-values for the IDI and continuous NRI, as well as the C-index and differences between models, a standard boot-
strap method was used with resampling performed 1,000 times. We also assessed the continuous NRI and IDI at 
the final follow-up visit (30 days) to assess the improvement in performance of the survival model when DNI (as an 
additional parameter) is included9,33,34. To identify the effect of early significant intervention including transfusion, 
embolization, and surgery on the predictability of DNI values, we reviewed medical records to identify patients who 
received significant intervention before obtaining DNI within 12 h after ED admission. We compared the predicta-
bility of DNI values for the development of MODS and the 30-day mortality between those that received early inter-
vention and those that had more conservative management using ROC curves with Delong method and Harrell’s 
C-index. Statistical analyses were performed using SAS, version 9.2 (SAS Institute Inc., Cary, NC); R software, ver-
sion 3.2.5 for Windows (the R foundation for statistical computing, Vienna, Austria; http://www.R-project.org/); 
and MedCalc, version 12.7.0 (MedCalc Software, Ostend, Belgium). A p-value < 0.05 was considered significant.
Ethics approval and consent to participate. The study was approved by the institutional review board 
(No. 3-2017-0188) of Yonsei University Health System, which waived the requirement for written informed con-
sent because of the retrospective nature of the study. All methods were performed in accordance with the relevant 
guidelines and regulations.
Availability of Data and Materials
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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